Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The pathophysiology of benign prostatic hyperplasia.

J D McConnell1

  • 1Division of Urology, University of Texas Southwestern Medical Center, Dallas.

Journal of Andrology
|November 1, 1991
PubMed
Summary

Benign prostatic hyperplasia (BPH) pathophysiology remains unclear, with symptoms arising from more than just prostate size. Bladder dysfunction and neural changes also significantly contribute to BPH symptoms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prostate cancer: where are we?

Proceedings (Baylor University. Medical Center)·2006
Same author

The development of urology in the 21st century.

BJU international·2001
Same author

5 alpha-Reductase inhibitors.

Advances in protein chemistry·2001
Same author

Laparoscopic gonadectomy and excision of müllerian remnant in an adult intersex patient.

Urology·2001
Same author

Contractile protein expression in bladder smooth muscle is a marker of phenotypic modulation after outlet obstruction in the rabbit model.

The Journal of urology·2001
Same author

Alpha-blockade downregulates myosin heavy chain gene expression in human benign prostatic hyperplasia.

Urology·2001

Area of Science:

  • Urology
  • Men's Health
  • Aging

Background:

  • Benign prostatic hyperplasia (BPH) is highly prevalent in aging males.
  • The exact causes and mechanisms of BPH pathophysiology are not fully understood.
  • Traditional views of BPH symptoms solely due to urethral obstruction are insufficient.

Purpose of the Study:

  • To explore the complex pathophysiology of benign prostatic hyperplasia.
  • To investigate the contributing factors beyond simple urethral resistance in BPH.
  • To highlight the need for deeper understanding to develop new treatments.

Main Methods:

  • Review of existing research on BPH etiology and progression.
  • Analysis of cellular and physiological changes associated with BPH.
  • Examination of the relationship between obstruction and bladder/prostate alterations.

Main Results:

  • BPH symptoms are not solely caused by increased urethral resistance from prostate size.
  • Obstruction-induced detrusor dysfunction is a major contributor to BPH symptoms.
  • Neural alterations in the bladder and prostate play a role in BPH symptomatology.

Conclusions:

  • The pathophysiology of BPH is more complex than previously thought.
  • Understanding these complexities is crucial for developing effective BPH treatments and prevention strategies.
  • Further research is needed to unravel the intricate cellular pathologies of BPH.

Related Experiment Videos